Deep Learning + Biomarker Platform

Empowering Precision in Breast Cancer Detection

A deep learning and biomarker-based platform that integrates AI algorithms with proprietary biomarker panels to significantly enhance the accuracy and efficiency of mammogram screenings.

ACR BI-RADS Compliant
Enterprise Security
AI-powered breast cancer screening visualization
The Problem

Breast Cancer Screening Is Broken

Despite advances in medical imaging, critical gaps in accuracy, speed, and accessibility leave millions of women at risk.

2.3M

New cases per year

Breast cancer is the most common cancer in women worldwide

30%

Missed in dense tissue

Standard mammography misses up to 30% of cancers in dense breasts

50%

False positives

Over 10 years of screening, ~50% of women experience a false positive

4-6 wks

Average report time

Patients often wait weeks for results due to radiologist shortages

Our Mission

Save Lives Through AI-Enhanced Early Detection

Sein Medical is building the next generation of breast cancer screening technology. By integrating advanced AI algorithms with proprietary biomarker panels, we deliver significantly higher accuracy while reducing false positives and shortening the time from screening to results.

Our vision is to eradicate breast cancer deaths globally by advancing early detection through robust, affordable, and accessible technology. We believe every woman deserves access to the most advanced screening tools, regardless of where she lives.

20+

Published research papers in breast cancer

3

Founders with Ph.D.-level expertise in biomedicine

Professional medical workspace with AI analysis tools
How It Works

From Image to Insight in Under 60 Seconds

A four-stage pipeline that combines data collection, AI analysis, biomarker integration, and professional review.

01

Data Collection

Patient Profile & Images

Create a patient profile with biomarkers and risk factors. Upload mammogram images (CC and MLO views) securely via encrypted transfer.

02

AI Analysis

Deep Learning & Biomarkers

Our AI processes images through advanced vision models, integrating biomarker panels and patient history for context-aware analysis.

03

Clinical Report

BI-RADS Classification

Structured findings with BI-RADS 0-6 classification (including 4A/4B/4C), mass characterization, and clinical recommendations.

04

Professional Review

Physician Confirmation

Physician reviews AI findings, adds clinical notes, confirms or adjusts the assessment, and generates the final PDF report.

The Platform

Built for Clinical Workflows

A professional dashboard designed for radiologists and physicians. Seamlessly integrates into existing healthcare systems at clinics, hospitals, imaging labs, and research facilities.

Sein Medical AI dashboard showing analysis results
Platform Capabilities

Everything You Need, Nothing You Don't

End-to-end breast cancer screening analysis, from image upload to final report, with biomarker integration at every stage.

Deep Learning Analysis

Advanced vision AI trained on breast imaging patterns provides structured BI-RADS classification with detailed mass and calcification characterization.

Biomarker Integration

Proprietary biomarker panels and patient risk factors are integrated into every analysis for truly personalized screening results.

Automated Radiology Reports

Generate comprehensive reports with findings, impressions, and ACR-compliant recommendations. Export as professional PDF.

AI Clinical Assistant

Per-patient AI chat that understands the full clinical context. Ask follow-up questions and get evidence-based responses.

Risk Stratification

Comprehensive risk assessment combining personal history, family history, genetic markers, and biomarker data into actionable scores.

Longitudinal Tracking

Compare current and previous screenings side-by-side. Track BI-RADS category changes and finding progression over time.

Why Sein Medical

What Sets Us Apart

Sein Medical's commitment to innovation and personalized treatment sets it apart in breast cancer detection.

Biomarker-Integrated AI

Unlike pure-imaging solutions, we combine proprietary biomarker panels with deep learning for significantly higher accuracy.

Full ACR BI-RADS Coverage

Complete BI-RADS 0-6 classification including sub-categories (4A, 4B, 4C) following American College of Radiology guidelines.

Results in Seconds

From image upload to structured BI-RADS report in under 60 seconds. Eliminate the weeks-long wait for screening results.

Enterprise-Grade Security

End-to-end encryption, role-based access, private storage, and full audit logging. Designed for healthcare compliance.

Seamless Integration

Designed to integrate into existing clinical workflows at private clinics, imaging labs, hospitals, and research facilities.

Patient-Centric Design

Built with patient outcomes as the north star. Every feature is designed to improve early detection and reduce unnecessary anxiety.

AI neural network analysis visualization
The Technology

Deep Learning Meets Biomarker Science

Our platform integrates AI algorithms and deep learning methods with proprietary biomarker panels to deliver a more reliable and precise screening process, reducing the risks of false negatives and false positives.

Biomarker-enhanced analysis

Proprietary panels integrated into every screening

Advanced vision AI

State-of-the-art deep learning for mammogram analysis

ACR BI-RADS compliant

Full classification system (0-6) with sub-categories

Under 60-second turnaround

From image upload to structured clinical report

Our Team

Led by Domain Experts

Our founders bring together a unique blend of expertise in biomedicine, biophysics, cancer biology, genetic engineering, and biotechnology.

Dr. Minoo Shahani

Dr. Minoo Shahani

Founder & CEO

Two Ph.D. degrees in Biomedicine (Breast Cancer Biology) and Biophysics. 20+ published papers in breast cancer research.

LinkedIn
Dorsa Gharagozloo

Dorsa Gharagozloo

Chief Clinical Officer

Research assistant in biotechnology and genetics. Published top-level papers across multiple research labs.

LinkedIn
Dr. Fatemeh Ahmadpour

Dr. Fatemeh Ahmadpour

Chief Operating Officer

Gynecologic oncologist and faculty member. Leads research groups and drives operations in Canada.

LinkedIn

Our Partners & Collaborators

Arete
Iranian Person-Centered Medicine
CRC
Market Opportunity

A Growing Global Need

The global healthcare landscape is witnessing a growing demand for advanced breast cancer detection solutions. Digital mammography adoption is accelerating, and government initiatives worldwide are promoting AI integration in healthcare.

Radiologist shortages mean AI-powered solutions are essential for managing large datasets efficiently, automating routine tasks, and enhancing diagnostic accuracy. Sein Medical is positioned to meet this demand with a cost-effective, easily accessible solution for healthcare providers globally.

$5.3B

AI in medical imaging market by 2028

36%

CAGR in AI-powered diagnostics

76M+

Mammograms performed annually in NA

99%

Survival rate with early detection

Frequently Asked Questions

Common questions about Sein Medical's platform and technology.

Ready to Transform Your Screening Workflow?

Join healthcare professionals who are using AI-powered tools to improve breast cancer detection accuracy and patient outcomes.

Based in North Vancouver, BC, Canada